Posts Written
38
Posts Written
225
Craig Wiggins
30+ years of supply chain financing and credit, and all you’ll ever need to know about g
Posts Written
227
Andrew Udell
Subject matter expert in physical & financial commodity trading, 20+ years professiona
Trending Posts
Keep updated with our most popular posts.
On November 4, 2018 TheCannalysts toured Aphria Diamond and Aphria1. Other than touring Broken Coast Cannabis for the “Boots on the Ground” documentary, this was the first time that all three Cannalysts have done a tour together. What follows is each of our perspectives on the tour. Mollytime: Unlike my compatriots, I haven’t toured a large-scale formal greenhouse before. I’ve been confined to the pristine shoals of immaculate control: indoor only. So, being introduced to read more
On November 4, 2018 TheCannalysts toured Aphria Diamond and Aphria1. Other than touring Broken Coast Cannab read more
Graham Jones of TheCannalysts moderates. https://www.youtube.com/watch?v=g-S9PIxkPV0&feature=youtu.be Featuring: Gordon Hagen - Lead Chemist Cronos Group Loren DeFalco Partner - CB1 Capital Dr. Guy Chamberland - CEO TetraBioPharma Dr. Jeremy Riggle - Chief Scientist Mary’s Medicinals read more
Graham Jones of TheCannalysts moderates. https://www.youtube.com/watch?v=g-S9PIxkPV0&feature=youtu.be Fe read more
Join Our Newsletter
Join our newsletter to get weekly updates about news and some other awesome content. Don't worry we won't do spam.
Submitting, please wait...
Success, we have sent you a confirmation email.
Error !!!
Editor Picks
Favorite topics from our editors.
Technology
Last quarter, we noted some *ahem* concerns around the balance sheet: anemic revenues and margins, asset impairments, and an outlook that was looking rather bleak. At least in my read more
Last quarter, we noted some *ahem* concerns around the balance sheet: anemic revenues and margins, asset impa read more
Food & Beverage
Last quarter, we noted some *ahem* concerns around the balance sheet: anemic revenues and margins, asset impairments, and an outlook that was looking rather bleak. At least in my read more
Last quarter, we noted some *ahem* concerns around the balance sheet: anemic revenues and margins, asset impa read more
Latest Posts
Our newest posts, fresh from the oven.
